SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-065314
Filing Date
2023-03-09
Accepted
2023-03-09 07:37:06
Documents
15
Period of Report
2023-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d479992d8k.htm   iXBRL 8-K 29124
2 EX-99.1 d479992dex991.htm EX-99.1 122960
7 GRAPHIC g479992g0309074325006.jpg GRAPHIC 7282
  Complete submission text file 0001193125-23-065314.txt   340937

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tmb-20230309.xsd EX-101.SCH 3897
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20230309_def.xml EX-101.DEF 14099
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20230309_lab.xml EX-101.LAB 23478
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20230309_pre.xml EX-101.PRE 15131
9 EXTRACTED XBRL INSTANCE DOCUMENT d479992d8k_htm.xml XML 6648
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 23718214
SIC: 2834 Pharmaceutical Preparations